Christian Marth
Papers
2
Total Citations
28
H-Index
2
About
Christian Marth is a leading figure in gynecologic oncology, with research centered on improving surgical outcomes for women with cervical and endometrial cancers. His most transformative contribution is the landmark SHAPE trial (CCTG CX.5), a phase III randomized study comparing radical hysterectomy to simple hysterectomy for low-risk early-stage cervical cancer. This practice-changing work, published in 2023, demonstrated that less radical surgery is non-inferior for survival while significantly reducing morbidity, reshaping global treatment guidelines. With over 26 citations already, the SHAPE trial underscores Marth’s impact on de-escalating surgical aggressiveness without compromising oncologic safety. Earlier, he explored the frontier of robotic surgery in gynecology, reporting on the feasibility of robot-assisted tubal reanastomosis in a 2002 study that helped pave the way for minimally invasive techniques in the field. Marth’s work consistently bridges rigorous clinical trial design with patient-centered outcomes, earning him recognition as a key voice in the Gynecologic Cancer Intergroup. His research empowers clinicians to tailor surgery to risk, offering women safer, less invasive options while maintaining excellent cancer control.
Research Focus
Key Achievements
Top Papers
- 1
- 2